It was revealed that FGD5-AS1 was highly expressed in pancreatic cancer tissues, and its overexpression facilitated the activation of the Wnt/β-catenin pathway and cancer progression via suppression of miR-577. The gene discussed is FGD5; the disease is pancreatic neoplasm.